The Hartford Insurance Group, Inc.
HIG
$129.11
-0.29%
The Hartford Insurance Group, Inc. is a diversified financial services holding company operating primarily in property and casualty insurance, group benefits, and mutual funds, with its largest segment being Business Insurance, complemented by Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds. As a 200-plus-year-old industry stalwart with roughly 19,200 employees, Hartford is a mainstream, well-recognized commercial and personal lines underwriter rather than a disruptor, competing on underwriting discipline, distribution scale, and service excellence against peers like Travelers, Chubb, and AIG. The current investor narrative centers on the tension between the company's consistent underwriting profitability and capital return program — highlighted by a Zacks note arguing investors should 'retain' the stock for its strong underwriting and buybacks — versus decelerating growth relative to peers and a stock that has materially lagged the broader market. Recent analyst actions have skewed cautious, with Mizuho downgrading to Neutral from Outperform in September 2026 and Piper Sandler moving to Neutral from Overweight in July 2026, reflecting concerns that the hard-market pricing tailwinds that boosted prior results are fading even as the company continues to generate solid earnings and return capital.…
HIG
The Hartford Insurance Group, Inc.
$129.11
Related headlines
Investment Opinion: Should I buy HIG Today?
The synthesized recommendation for HIG is a Hold, with a bias toward accumulation on weakness. The core thesis is that HIG is a financially sound, shareholder-friendly insurer trading at a deep discount (9.4x forward PE) with a 14.6% upside to the analyst average target of $148, but near-term growth deceleration and analyst downgrades limit catalysts. The consensus rating is 'Buy' (mean 2.39), yet the stock has lagged the market significantly, suggesting the market is pricing in persistent headwinds.
Supporting evidence for the Hold rating includes: 1) Valuation is attractive with a forward PE of 9.41 and PEG of 0.36, well below the market average; 2) Profitability is strong with a 20.2% ROE and 13.6% net margin, though gross margin has compressed to 34.6% in Q2 2026; 3) Free cash flow is robust at $5.87 billion TTM, funding buybacks that reduce share count and support EPS; 4) The dividend yield of 1.58% is modest but sustainable with a payout ratio of only 15.98%. However, revenue growth of 3.95% YoY is lackluster, and the stock's 1-year relative strength of -16.78% versus the S&P 500 is a clear negative.
The biggest risks that could invalidate the thesis are: 1) Further margin deterioration if insurance pricing weakens more than expected; 2) A sustained decline in investment income if interest rates fall; 3) Catastrophe losses exceeding reserves. The rating would upgrade to Buy if the stock pulls back to the 52-week low of $120.33 (offering a 6.8% discount and a higher dividend yield) or if gross margins stabilize above 40%. It would downgrade to Sell if revenue growth turns negative or if ROE falls below 15%. Relative to its history and peers, HIG appears undervalued on earnings, but the market is demanding evidence of sustainable growth before re-rating the stock.
Sign up to view all
HIG 12-Month Price Forecast
HIG presents a balanced risk/reward profile, with deep value metrics offset by growth challenges. The stock's 9.4x forward PE and 20.2% ROE are attractive, but decelerating revenue growth and margin compression warrant caution. Analyst sentiment is mixed, with a consensus Buy but recent downgrades. The low beta and stable dividend make it a defensive holding, but the lack of near-term catalysts may keep the stock range-bound. I would upgrade to bullish if gross margins stabilize above 40% and revenue growth accelerates to 5%+, and downgrade to bearish if margins fall below 30% or if the company misses earnings significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Hartford Insurance Group, Inc.'s 12-month outlook, with a consensus price target around $148.00 and implied upside of +14.6% versus the current price.
Average Target
$148.00
0 analysts
Implied Upside
+14.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$135 - $164
Analyst target range
Bulls vs Bears: HIG Investment Factors
The bear case currently has stronger evidence due to HIG's persistent underperformance (-16.78% relative strength over 1 year), decelerating revenue growth (3.95% YoY), and recent analyst downgrades. However, the bull case rests on compelling valuation (9.4x forward PE), strong ROE (20.2%), and robust free cash flow ($5.87B), which provide a margin of safety. The most critical tension is whether the company can sustain underwriting profitability as the hard insurance market softens; if margins hold, the stock is deeply undervalued, but if they deteriorate further, the low multiple could persist. The resolution of this debate will likely determine whether HIG reverts to its historical premium or remains a value trap.
Bullish
- Deep Value with 9.4x Forward PE: HIG trades at a forward PE of just 9.41x and a trailing PE of 10.20x, a significant discount to the broader market and many financial peers. With a PEG ratio of 0.36, the stock is priced for minimal growth despite consistent earnings power.
- Strong Profitability and ROE: The company generated a 20.2% return on equity and a 13.6% net margin, demonstrating efficient capital deployment. Operating margin stands at 16.8%, reflecting disciplined underwriting and expense management.
- Robust Free Cash Flow and Buybacks: TTM free cash flow is $5.87 billion, providing ample capacity for shareholder returns. The company actively repurchases shares, with shares outstanding declining from 292.6 million in Q4 2024 to 278.3 million in Q2 2026, boosting EPS.
- Analyst Consensus Buy with 14.6% Upside: Of 20 analysts covering HIG, the consensus recommendation is 'Buy' with an average target price of $148, implying 14.6% upside from the current $129.11. The low target of $135 still represents 4.6% upside, suggesting limited downside according to analysts.
Bearish
- Significant Underperformance vs. Market: HIG has declined 5.83% YTD and 0.78% over the past year, while the S&P 500 (SPY) gained 14.17% and 16.0% respectively. The relative strength over 1 year is -16.78%, indicating persistent laggard status.
- Decelerating Revenue Growth: Q2 2026 revenue grew only 3.95% year-over-year to $7.26 billion, a slowdown from prior periods. This moderate growth lags peers and suggests the hard-market pricing tailwinds are fading.
- Analyst Downgrades Signal Caution: Mizuho downgraded HIG to Neutral from Outperform in September 2026, and Piper Sandler moved to Neutral from Overweight in July 2026. These actions reflect concerns about peaking insurance pricing and limited near-term catalysts.
- Margin Compression in Q2 2026: Gross margin fell to 34.6% in Q2 2026 from 44.7% in Q1 2026 and 46.9% in Q2 2025. While some fluctuation is normal, the sharp sequential decline raises questions about underwriting profitability and cost trends.
HIG Technical Analysis
Beta
0.49
0.49x market volatility
Max Drawdown
-16.0%
Largest decline past year
52-Week Range
$120-$146
Price range past year
Annual Return
-0.8%
Cumulative gain past year
| Period | HIG Return | S&P 500 |
|---|---|---|
| 1m | -5.5% | +1.9% |
| 3m | -7.0% | +3.9% |
| 6m | -5.9% | +12.1% |
| 1y | -0.8% | +19.2% |
| ytd | -5.8% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HIG Fundamental Analysis
Quarterly Revenue
$7.3B
2026-06
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
34.6%
Latest Quarter
Free Cash Flow
$5.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HIG Overvalued?
PE
10.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks for HIG are moderate but noteworthy. The company carries a debt-to-equity ratio of 0.23, which is manageable, but its current ratio of 17.65 is unusually high, potentially indicating inefficient capital allocation or large cash reserves that could be deployed more productively. More concerning is the sharp decline in gross margin from 46.9% in Q2 2025 to 34.6% in Q2 2026, a 12.3 percentage point drop that suggests either rising claims costs or pricing pressure. Additionally, revenue growth has slowed to 3.95% year-over-year, and the company's earnings are sensitive to catastrophe losses and reserve adjustments, which can cause significant volatility. The payout ratio is low at 15.98%, but the dividend yield of 1.58% is modest, and any earnings miss could pressure the stock further.
Market and competitive risks are significant given HIG's underperformance and sector dynamics. The stock has a beta of 0.493, indicating low correlation with the market, but it has still declined 5.83% YTD while the S&P 500 gained 14.17%, highlighting idiosyncratic weakness. The insurance sector is highly competitive, with peers like Travelers, Chubb, and AIG also vying for market share; if pricing softens, HIG may struggle to maintain underwriting margins. Recent analyst downgrades from Mizuho and Piper Sandler reflect concerns that the hard-market pricing cycle is ending, which could compress margins across the industry. Furthermore, HIG's valuation, while low at 9.4x forward earnings, may remain depressed if growth continues to lag, leading to further relative underperformance.
The worst-case scenario for HIG would involve a combination of accelerating margin deterioration, catastrophic losses, and a continued decline in insurance pricing. If gross margins fall below 30% and revenue growth turns negative, earnings could drop sharply, potentially pushing the stock toward its 52-week low of $120.33, which represents a 6.8% decline from the current price of $129.11. In a more severe scenario, if the company misses earnings and analysts cut targets to the low end of $135 (which is above current price, but could be revised lower), the stock could test $110-$115, implying a 10-15% downside. The max drawdown over the past 180 days is -16.01%, and a similar drawdown from current levels would take the stock to approximately $108.45, a 16% loss. Investors should be prepared for potential losses of 10-20% in a bear case.
FAQ
The key risks for HIG include: 1) Financial risk: Gross margin declined to 34.6% in Q2 2026 from 46.9% a year earlier, indicating potential underwriting pressure. 2) Competitive risk: The insurance market is softening, and peers like Travelers and Chubb are competing aggressively, which could lead to pricing declines. 3) Macro risk: With a beta of 0.493, HIG is less sensitive to market swings, but low interest rates could reduce investment income. 4) Company-specific risk: Recent analyst downgrades (Mizuho and Piper Sandler to Neutral) suggest limited near-term catalysts. The most severe risk is a combination of margin compression and catastrophe losses, which could push the stock toward its 52-week low of $120.33.
Our 12-month forecast for HIG includes three scenarios: Bull case (25% probability) targets $148-$164, assuming margin recovery and revenue acceleration; Base case (55% probability) targets $135-$148, expecting stable growth and margins; Bear case (20% probability) targets $120-$135, driven by margin compression and competitive pressures. The base case is most likely, with the stock gradually appreciating toward the analyst average target of $148 as earnings grow modestly. The key assumption is that gross margins stabilize around 35-40% and no major catastrophe losses occur. However, if margins deteriorate further, the bear case could materialize.
HIG appears undervalued based on earnings multiples. Its forward PE of 9.41x and trailing PE of 10.20x are well below the broader market's average, and its PEG ratio of 0.36 suggests the market is pricing in minimal growth. The price-to-book ratio of 2.05 is moderate for an insurer with a 20.2% ROE. Compared to peers, HIG trades at a discount, likely due to its slower growth and recent analyst downgrades. The market seems to expect continued margin pressure and low growth; if the company can stabilize margins, the multiple could expand. However, the low valuation also reflects legitimate concerns about the softening insurance cycle.
HIG can be a good buy for value-oriented investors, given its forward PE of 9.41x and 14.6% upside to the analyst average target of $148. The company's 20.2% ROE and $5.87 billion in free cash flow demonstrate strong profitability and cash generation. However, the stock has underperformed the market by 16.78% over the past year, and revenue growth is only 3.95% year-over-year. The biggest downside risk is a further decline to the 52-week low of $120.33, representing a 6.8% drop. For those with a long-term horizon and tolerance for near-term volatility, HIG offers a compelling risk/reward, but it may not be suitable for investors seeking high growth.
HIG is more suitable for long-term investment due to its low beta (0.493), stable dividend (1.58% yield), and consistent buybacks, which reward patient shareholders. The stock's recent underperformance and lack of near-term catalysts make it less attractive for short-term trading. Earnings visibility is moderate, with quarterly fluctuations due to catastrophe losses. A minimum holding period of 2-3 years is recommended to allow for potential multiple expansion and dividend compounding. Short-term traders might find opportunities around earnings announcements, but the overall trend has been downward, so timing is risky. Long-term investors can benefit from the company's strong fundamentals and capital returns.